Design, synthesis, and antiproliferative evaluation of dihydropyrimidinone-pyrazole derivatives as potential SHP2 inhibitors via in silico target prediction

Compounds 14 and 27 are established as promising anticancer candidates worthy of further development. Future work will focus on comprehensive in vivo efficacy studies and deeper mechanistic investigation to advance this novel chemical series.